These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 3548632

  • 1. [Allogeneic bone marrow transplantation in acute lymphoblastic leukemia of children. Analysis of prognostic factors. GEGMO (Bone Marrow Study Group) study].
    Bordigoni P, Vernant JP, Souillet G, Philippe N, Maraninchi D.
    Arch Fr Pediatr; 1986 Dec; 43(10):765-8. PubMed ID: 3548632
    [Abstract] [Full Text] [Related]

  • 2. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF.
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [Abstract] [Full Text] [Related]

  • 3. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
    Long GD, Amylon MD, Stockerl-Goldstein KE, Negrin RS, Chao NJ, Hu WW, Nademanee AP, Snyder DS, Hoppe RT, Vora N, Wong R, Niland J, Reichardt VL, Forman SJ, Blume KG.
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
    [Abstract] [Full Text] [Related]

  • 4. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia.
    Brochstein JA, Kernan NA, Groshen S, Cirrincione C, Shank B, Emanuel D, Laver J, O'Reilly RJ.
    N Engl J Med; 1987 Dec 24; 317(26):1618-24. PubMed ID: 3317056
    [Abstract] [Full Text] [Related]

  • 5. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
    Moussalem M, Esperou Bourdeau H, Devergie A, Baruchel A, Ribaud P, Socie G, Parquet N, Traineau R, Hirsch I, Schaison G.
    Bone Marrow Transplant; 1995 Jun 24; 15(6):943-7. PubMed ID: 7581095
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
    Michel G, Leverger G, Leblanc T, Nelken B, Baruchel A, Landman-Parker J, Thuret I, Bergeron C, Bordigoni P, Esperou-Bourdeau H, Perel Y, Vannier JP, Schaison G.
    Bone Marrow Transplant; 1996 Feb 24; 17(2):191-6. PubMed ID: 8640165
    [Abstract] [Full Text] [Related]

  • 7. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S, Naparstek E, Nagler A, Ackerstein A, Kapelushnik J, Or R.
    Exp Hematol; 1995 Dec 24; 23(14):1553-62. PubMed ID: 8542946
    [Abstract] [Full Text] [Related]

  • 8. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group.
    Borgmann A, Hartmann R, Schmid H, Klingebiel T, Ebell W, Göbel U, Peters C, Gadner H, Henze G.
    Bone Marrow Transplant; 1995 Apr 24; 15(4):515-21. PubMed ID: 7655375
    [Abstract] [Full Text] [Related]

  • 9. Allogeneic bone marrow transplantation versus chemotherapy in the treatment of childhood acute lymphoblastic leukemia in second complete remission.
    Torres A, Martínez F, Gómez P, Fornés G, Rojas R, Herrera C, Gómez JL, Manzanares R, García JM, Andres P.
    Bone Marrow Transplant; 1989 Nov 24; 4(6):609-12. PubMed ID: 2819281
    [Abstract] [Full Text] [Related]

  • 10. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
    Badell I, Ortega JJ, Muñoz A, Bureo E, Madero L, Olivé T, Cubells J, Maldonado MS, Baro J, Díaz MA.
    Sangre (Barc); 1996 Apr 24; 41(2):101-8. PubMed ID: 9045349
    [Abstract] [Full Text] [Related]

  • 11. Role of total body irradiation as based on the comparison of preparation regimens for allogeneic bone marrow transplantation for acute leukemia in first complete remission.
    Inoue T, Ikeda H, Yamazaki H, Tang JT, Song C, Teshima T, Murayama S, Ohtani M, Shibata H, Masaoka T.
    Strahlenther Onkol; 1993 Apr 24; 169(4):250-5. PubMed ID: 8488461
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
    Mehta J, Powles R, Treleaven J, Horton C, Tait D, Meller S, Pinkerton CR, Middleton G, Eisen T, Singhal S.
    Bone Marrow Transplant; 1996 Oct 24; 18(4):741-6. PubMed ID: 8899189
    [Abstract] [Full Text] [Related]

  • 13. [Allogeneic bone marrow transplantation in the treatment of acute leukemias of children. Study of 26 patients].
    Michel G, Maraninchi D, Perrimond H, Mascret B, Orsini A, Gastaut JA, Raybaud C, Blaise D, Demeocq F, Sebahoun G.
    Arch Fr Pediatr; 1986 Dec 24; 43(10):769-74. PubMed ID: 3548633
    [Abstract] [Full Text] [Related]

  • 14. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
    Jillella AP, Doria R, Khan K, Zelterman D, Ahmad YH, Smith BR, Holmes W, Becker P, Roberts KB, Rappeport JM.
    Bone Marrow Transplant; 1999 Jun 24; 23(11):1095-100. PubMed ID: 10382947
    [Abstract] [Full Text] [Related]

  • 15. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
    Parsons SK, Castellino SM, Lehmann LE, Eickhoff CE, Tarbell NJ, Sallan SE, Weinstein HJ, Billett AL.
    Bone Marrow Transplant; 1996 May 24; 17(5):763-8. PubMed ID: 8733695
    [Abstract] [Full Text] [Related]

  • 16. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ, Díaz de Heredia C, Olivé T, Bastida P, Llort A, Armadans L, Torrabadella M, Massuet L.
    Haematologica; 2003 Mar 24; 88(3):290-9. PubMed ID: 12651268
    [Abstract] [Full Text] [Related]

  • 17. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma.
    Kamani N, August CS, Bunin N, Leahey A, Bayever E, Goldwein J, Zusman J, Evans AE, Angio GD.
    Bone Marrow Transplant; 1996 Jun 24; 17(6):911-6. PubMed ID: 8807093
    [Abstract] [Full Text] [Related]

  • 18. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
    De Witte T, Schattenberg A, Preijers F, Raymakers R, Muus P, Wessels J.
    Bone Marrow Transplant; 1993 Jun 24; 12 Suppl 3():S2-6. PubMed ID: 8124252
    [Abstract] [Full Text] [Related]

  • 19. Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative?
    Borgmann A, Baumgarten E, Schmid H, Dopfer R, Ebell W, Göbel U, Niethammer D, Gadner H, Henze G.
    Bone Marrow Transplant; 1997 Dec 24; 20(11):939-44. PubMed ID: 9422472
    [Abstract] [Full Text] [Related]

  • 20. [Fractionated and hyperfractionated total body irradiation in the conditioning of allogenic bone marrow transplant in acute lymphatic leukemia. Results].
    Corvò R, Frassoni F, Franzone P, Barra S, Guenzi M, Orsatti M, Fiorino R, Scarpati D, Vitale V.
    Radiol Med; 1989 Oct 24; 78(4):367-72. PubMed ID: 2687967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.